Valued at USD 28 billion, Brazil is the world's sixth largest pharmaceutical market, driven by growing public health expenditure and increasing household income.
from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2Pu4xto
via IFTTT
Home »
Healthcare/Biotech-Industry-The Economic Times
» Lupin enters prescription dermatology segment in Brazil
0 comments:
Post a Comment